2025年,根据花生过敏补丁的积极数据,DBV技术公司的库存猛增176%。 DBV Technologies' stock soars 176% in 2025 amid positive data for peanut allergy patch.

2025年,DBV Technologies S.A.(DBVT)正在取得显著增长,其库存达到最新年份的176.05%,在不断膨胀的保健库存中排名第六。 DBV Technologies S.A. (DBVT) is seeing significant growth in 2025, with its stock up 176.05% year-to-date, ranking 6th among surging healthcare stocks. 这一激增归因于第三阶段研究得出的积极安全数据,使Viaskin Peanut Patch公司能够绕过进一步试验,并有可能快速实现市场释放。 The surge is attributed to positive safety data from a Phase 3 study, allowing the Viaskin Peanut Patch to bypass a further trial and potentially fast-tracking its market release. 协商一致价格目标为22.5美元,这意味着上调为163.77%。 The consensus price target of $22.5 implies an additional upside of 163.77%.